However, potential side effects include nausea, vomiting, diarrhea, abdominal pain, heartburn, constipation, or burping
Retatrutide is an investigational injectable peptide currently under clinical evaluation for the treatment of obesity and type 2 diabetes mellitus
From a patient perspective, monthly administration of GLP-1R-targeted NPs could help maintain disease remission while reducing dependence on corticosteroids and biologics
Recent trials investigating glucagon-like peptide-1 (GLP-1) receptor (GLP-1R) agonists (GLP-1RAs) for the treatment of NAFLD have shown promising results
Unlike heat damage, which can sometimes be partial and gradual, freezing damage is often total and irreversible